title: [Diferelin treatment of primary local and generalized cancer of the prostate].
authors.forename: G P
authors.initials: GP
authors.lastname: Kolesnikov
authors.forename: I G
authors.initials: IG
authors.lastname: Rusakov
authors.forename: L V
authors.initials: LV
authors.lastname: Shaplygin
authors.forename: S A
authors.initials: SA
authors.lastname: Voznesenskiĭ
authors.forename: A A
authors.initials: AA
authors.lastname: Bystrov
mesh_terms: D000230:Adenocarcinoma / Q000097:blood / Q000188:drug therapy* / Q000556:secondary / Q000601:surgery; D000368:Aged; D000369:Aged, 80 and over; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000556:secondary; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D008875:Middle Aged; D009919:Orchiectomy; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000097:blood / Q000188:drug therapy* / Q000601:surgery; D013739:Testosterone / Q000097:blood; D013997:Time Factors; D017329:Triptorelin Pamoate / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D018931:Antineoplastic Agents, Hormonal; D017329:Triptorelin Pamoate; D013739:Testosterone; D017430:Prostate-Specific Antigen
vernacular_title: Primenenie diferelina pri pervichno vyiavlennom mestno-rasprostranennom i generalizovannom rake predstatel'noĭ zhelezy.